TLX
Trans-Lux Corp.
NASDAQ · Healthcare · Biotechnology · AU
$9.57
+5.92%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 78.41x
- P/E 2027E
- 144.78x
- P/E 2028E
- 27.99x
- P/S forward
- 20.92x
Trailing multiples
Trailing twelve months
- P/E TTM
- 99.74x
- PEG TTM
- —
- Price / book
- 6.65x
- Price / sales
- 3.66x
- Price / cash flow
- -275.63x
Enterprise value
- Enterprise value
- $3.6B
- EV / sales
- 4.03x
- EV / EBITDA
- 115.01x
- EV / EBIT
- -494.49x
- Market cap
- $3.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026